Cargando…
Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors
SIMPLE SUMMARY: The expression of the catalytic subunit of the human telomerase reverse transcriptase subunit (hTERT) is hormonally controlled. Androgen treatment suppresses the hTERT expression at a transcriptional level in prostate cancer cells. Here, we identified the responsive promoter element...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391603/ https://www.ncbi.nlm.nih.gov/pubmed/34439179 http://dx.doi.org/10.3390/cancers13164025 |
_version_ | 1783743313403183104 |
---|---|
author | Bartsch, Sophie Mirzakhani, Kimia Neubert, Laura Stenzel, Alexander Ehsani, Marzieh Esmaeili, Mohsen Pungsrinont, Thanakorn Kacal, Merve Rasa, Seyed Mohammad Mahdi Kallenbach, Julia Damodaran, Divya Ribaudo, Federico Grimm, Marc-Oliver Neri, Francesco Baniahmad, Aria |
author_facet | Bartsch, Sophie Mirzakhani, Kimia Neubert, Laura Stenzel, Alexander Ehsani, Marzieh Esmaeili, Mohsen Pungsrinont, Thanakorn Kacal, Merve Rasa, Seyed Mohammad Mahdi Kallenbach, Julia Damodaran, Divya Ribaudo, Federico Grimm, Marc-Oliver Neri, Francesco Baniahmad, Aria |
author_sort | Bartsch, Sophie |
collection | PubMed |
description | SIMPLE SUMMARY: The expression of the catalytic subunit of the human telomerase reverse transcriptase subunit (hTERT) is hormonally controlled. Androgen treatment suppresses the hTERT expression at a transcriptional level in prostate cancer cells. Here, we identified the responsive promoter element that mediates the androgen receptor induced transrepression of hTERT. The negative androgen response element (nARE) is identified as 62 bp located in the core promoter of hTERT. Chromatin immunoprecipitations indicate an androgen-dependent recruitment of the androgen receptor (AR) ING1 and ING2 to the hTERT promoter. Interestingly, the androgen-induced transrepression is mediated by the class II tumor suppressors inhibitor of growth 1 and 2, namely ING1 and ING2, respectively. ABSTRACT: The human telomerase is a key factor during tumorigenesis in prostate cancer (PCa). The androgen receptor (AR) is a key drug target controlling PCa growth and regulates hTERT expression, but is described to either inhibit or to activate. Here, we reveal that androgens repress and activate hTERT expression in a concentration-dependent manner. Physiological low androgen levels activate, while, notably, supraphysiological androgen levels (SAL), used in bipolar androgen therapy (BAT), repress hTERT expression. We confirmed the SAL-mediated gene repression of hTERT in PCa cell lines, native human PCa samples derived from patients treated ex vivo, as well as in cancer spheroids derived from androgen-dependent or castration resistant PCa (CRPC) cells. Interestingly, chromatin immuno-precipitation (ChIP) combined with functional assays revealed a positive (pARE) and a negative androgen response element (nARE). The nARE was narrowed down to 63 bp in the hTERT core promoter region. AR and tumor suppressors, inhibitor of growth 1 and 2 (ING1 and ING2, respectively), are androgen-dependently recruited. Mechanistically, knockdown indicates that ING1 and ING2 mediate AR-regulated transrepression. Thus, our data suggest an oppositional, biphasic function of AR to control the hTERT expression, while the inhibition of hTERT by androgens is mediated by the AR co-repressors ING1 and ING2. |
format | Online Article Text |
id | pubmed-8391603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83916032021-08-28 Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors Bartsch, Sophie Mirzakhani, Kimia Neubert, Laura Stenzel, Alexander Ehsani, Marzieh Esmaeili, Mohsen Pungsrinont, Thanakorn Kacal, Merve Rasa, Seyed Mohammad Mahdi Kallenbach, Julia Damodaran, Divya Ribaudo, Federico Grimm, Marc-Oliver Neri, Francesco Baniahmad, Aria Cancers (Basel) Article SIMPLE SUMMARY: The expression of the catalytic subunit of the human telomerase reverse transcriptase subunit (hTERT) is hormonally controlled. Androgen treatment suppresses the hTERT expression at a transcriptional level in prostate cancer cells. Here, we identified the responsive promoter element that mediates the androgen receptor induced transrepression of hTERT. The negative androgen response element (nARE) is identified as 62 bp located in the core promoter of hTERT. Chromatin immunoprecipitations indicate an androgen-dependent recruitment of the androgen receptor (AR) ING1 and ING2 to the hTERT promoter. Interestingly, the androgen-induced transrepression is mediated by the class II tumor suppressors inhibitor of growth 1 and 2, namely ING1 and ING2, respectively. ABSTRACT: The human telomerase is a key factor during tumorigenesis in prostate cancer (PCa). The androgen receptor (AR) is a key drug target controlling PCa growth and regulates hTERT expression, but is described to either inhibit or to activate. Here, we reveal that androgens repress and activate hTERT expression in a concentration-dependent manner. Physiological low androgen levels activate, while, notably, supraphysiological androgen levels (SAL), used in bipolar androgen therapy (BAT), repress hTERT expression. We confirmed the SAL-mediated gene repression of hTERT in PCa cell lines, native human PCa samples derived from patients treated ex vivo, as well as in cancer spheroids derived from androgen-dependent or castration resistant PCa (CRPC) cells. Interestingly, chromatin immuno-precipitation (ChIP) combined with functional assays revealed a positive (pARE) and a negative androgen response element (nARE). The nARE was narrowed down to 63 bp in the hTERT core promoter region. AR and tumor suppressors, inhibitor of growth 1 and 2 (ING1 and ING2, respectively), are androgen-dependently recruited. Mechanistically, knockdown indicates that ING1 and ING2 mediate AR-regulated transrepression. Thus, our data suggest an oppositional, biphasic function of AR to control the hTERT expression, while the inhibition of hTERT by androgens is mediated by the AR co-repressors ING1 and ING2. MDPI 2021-08-10 /pmc/articles/PMC8391603/ /pubmed/34439179 http://dx.doi.org/10.3390/cancers13164025 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bartsch, Sophie Mirzakhani, Kimia Neubert, Laura Stenzel, Alexander Ehsani, Marzieh Esmaeili, Mohsen Pungsrinont, Thanakorn Kacal, Merve Rasa, Seyed Mohammad Mahdi Kallenbach, Julia Damodaran, Divya Ribaudo, Federico Grimm, Marc-Oliver Neri, Francesco Baniahmad, Aria Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors |
title | Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors |
title_full | Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors |
title_fullStr | Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors |
title_full_unstemmed | Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors |
title_short | Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors |
title_sort | antithetic htert regulation by androgens in prostate cancer cells: htert inhibition is mediated by the ing1 and ing2 tumor suppressors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391603/ https://www.ncbi.nlm.nih.gov/pubmed/34439179 http://dx.doi.org/10.3390/cancers13164025 |
work_keys_str_mv | AT bartschsophie antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT mirzakhanikimia antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT neubertlaura antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT stenzelalexander antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT ehsanimarzieh antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT esmaeilimohsen antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT pungsrinontthanakorn antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT kacalmerve antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT rasaseyedmohammadmahdi antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT kallenbachjulia antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT damodarandivya antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT ribaudofederico antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT grimmmarcoliver antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT nerifrancesco antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors AT baniahmadaria antithetichtertregulationbyandrogensinprostatecancercellshtertinhibitionismediatedbytheing1anding2tumorsuppressors |